Table 1 Characteristics of 63 pancreas cancer patients
Characteristics | No. of patients, n = 63 |
|---|---|
Sex | |
Male | 43 (68.3%) |
Female | 20 (31.7%) |
Age (Median) | 62 (40–82) |
Stage | |
Locally advanced | 31 (49.2%) |
Metastatic | 32 (50.8%) |
Tumor location | |
Head | 23 (36.5%) |
Body/tail | 40 (63.5%) |
Tumor size* (median) | 4.6 cm (2.5 cm - 9.3 cm) |
Diagnostic mode | |
Histological/cytological | 45 (71.4%) |
Clinical | 18 (28.6%) |
CA19–9 at diagnosis | |
≥ 1000 U/ml | 25 (39.7%) |
< 1000 U/ml | 33 (52.4%) |
Missing | 5 (7.9%) |
CEA at diagnosis | |
>10 ng/ml | 13 (20.6%) |
≤10 ng/ml | 41 (65.1%) |
Missing | 9 (14.3%) |
Concurrent chemotherapy | |
Yes | 27 (42.9%) |
No | 36 (57.1%) |
Systemic chemotherapy | |
Yes | 26 (41.3%) |
No | 37 (58.7%) |
RIAC | |
Yes | 39 (61.9%) |
No | 24 (38.1%) |